Furthermore, high expression of DLL-4 has been shown to be correlated with glioma angiogenesis (Nandhu et al., 2014), and Notch activation via gp130/STAT3 signaling confers resistance to chemoradiotherapy (Koerdel et al., 2021). Here, DLL4 is linked to central nervous system cancer.